The Harvard School of Dental Medicine, with support from StrataDx, will present the latest in detection and treatment of mucosal disease. The lectures are designed to provide oral surgeons, periodontists, and endodontists further education on topics related to oral pathology. After completing the courses, clinicians will have broader knowledge of:
- Diagnostic aspects and pitfalls of mucosal disease, use of steroids and other medications in the mouth, and common interpretations of radiographic ﬁndings
- Understanding of molecular ﬁndings in odontogenic cysts and tumors
- Introduction to new cancer therapy such as topical chemotherapy, check point inhibitor therapy and novel muco-adhesive agents
The cost of the course is $300 and participants will earn six CE credits.
Cancellation Deadline for Full Refund: April 16, 2021
9:00-10:00am: Immunotherapy in Head and Neck Cancer by Glenn Hanna, MD
10:00-11:00am: Oral White Lesions and New Concepts of Oral Leukoplakia by Sook-Bin Woo DMD, FDSRCS (Edin)
11:15am-12:15pm: Update on HPV and Molecular Changes in Odontogenic Cysts and Tumors by Sook-Bin Woo DMD, FDSRCS (Edin)
1:00-2:00pm: Guidelines for the Diagnosis and Management of Oral Ulcerative Conditions by Vikki Noonan DMD, DMSc
2:00-3:00pm: Interesting Cases in Oral Pathology: Systemic Diseases with Oral Manifestations by Vikki Noonan DMD, DMSc
3:00– 3:15pm: Break
3:15-4:15pm: Tips and Hints to Aid in Successful Radiographic Interpretation by Bernard Friedland, BDS, MSc, JD
4:15-4:30pm: Question & Answer, Closing Remarks
Harvard School of Dental Medicine is an ADA CERP Recognized Provider
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. The Harvard School of Dental Medicine designated this activity for 1 continuing education credit.